Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
glycoprotein hormone
|
| gptkbp:actsOn |
bone marrow
|
| gptkbp:bannedIn |
sports (doping)
|
| gptkbp:category |
hematopoietic growth factor
|
| gptkbp:discoveredIn |
1906
|
| gptkbp:gene |
gptkb:EPO
|
| gptkbp:halfLife |
4-13 hours
|
| gptkbp:hasApprovedDrug |
gptkb:epoetin_beta
gptkb:darbepoetin_alfa gptkb:epoetin_alfa |
| https://www.w3.org/2000/01/rdf-schema#label |
Erythropoietins
|
| gptkbp:medicalUse |
chronic kidney disease
chemotherapy-induced anemia |
| gptkbp:molecularWeight |
30.4 kDa
|
| gptkbp:producedBy |
kidneys
liver (in fetus) |
| gptkbp:promotion |
red blood cell production
|
| gptkbp:recipient |
erythropoietin receptor
|
| gptkbp:regulates |
gptkb:hypoxia
|
| gptkbp:sideEffect |
hypertension
thromboembolism |
| gptkbp:structure |
contains 165 amino acids
|
| gptkbp:usedFor |
gptkb:anemia
|
| gptkbp:bfsParent |
gptkb:EPOs
|
| gptkbp:bfsLayer |
7
|